Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
TORONTO and HAIFA, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company...
 - 
                            
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update